Earwax removal: not just about cleaning your ears.
Earwax is a natural secretion that confers physical, immunological and chemical protection to ear. However, the excessive accumulation can cause symptoms such as, hearing loss, pain, itching, tinnitus, odour and dizziness.
Excessive or impacted earwax is present in one in 10 children and one in 20 adults. It is particularly prevalent in geriatric population, with more than one third affected.
OTIBLOCK® is a Medical Device scientifically formulated to remove earwax from the external ear canal.
OTIBLOCK®, available as spray and drops, was launched in Spain in 2016 backed by ENT specialists’ opinion, and is now commercialized in 12 countries.
The product has two main advantages over the existing options in the market:
- A slightly acidic external ear canal pH plays a key role precluding bacterial growth. This pH is often neglected, and most of the available products on the market to treat earwax impaction, have an alkaline pH. OTIBLOCK® is formulated with a buffer solution to help to maintain the correct pH.
- OTIBLOCK® works as a true cerumenolytic, breaking earwax down in contrast to many oil-based products that work only as lubricants. Thanks to its cerumenolytic properties can prevent in many cases from further ENT manipulation and this property makes OTIBLOCK® particularly appropriate as a preventive treatment for people prone to the formation of earwax plugs.
Earwax removal: not just about cleaning your ears.
Earwax is a natural secretion that confers physical, immunological and chemical protection to ear. However, the excessive accumulation can cause symptoms such as, hearing loss, pain, itching, tinnitus, odour and dizziness.
Excessive or impacted earwax is present in one in 10 children and one in 20 adults. It is particularly prevalent in geriatric population, with more than one third affected.
OTIBLOCK® is a Medical Device scientifically formulated to remove earwax from the external ear canal.
OTIBLOCK®, available as spray and drops, was launched in Spain in 2016 backed by ENT specialists’ opinion, and is now commercialized in 12 countries.
The product has two main advantages over the existing options in the market:
- A slightly acidic external ear canal pH plays a key role precluding bacterial growth. This pH is often neglected, and most of the available products on the market to treat earwax impaction, have an alkaline pH. OTIBLOCK® is formulated with a buffer solution to help to maintain the correct pH.
- OTIBLOCK® works as a true cerumenolytic, breaking earwax down in contrast to many oil-based products that work only as lubricants. Thanks to its cerumenolytic properties can prevent in many cases from further ENT manipulation and this property makes OTIBLOCK® particularly appropriate as a preventive treatment for people prone to the formation of earwax plugs.
OTIDRY-MD®
Because a dry ear is a healthy ear.
Acute Otitis Externa (AOE) -also known as Swimmer’s Ear”- is a common problem encountered in emergency medicine especially in the summer months. The symptoms are ear discomfort (ranging from pruritus till severe pain), otorrhea (ear discharge) and in case of severe swelling, aural fullness and loss of hearing.
In 2017, 2.4 million U.S. health care visits resulted in a diagnosis of AOE annually which represents 0.8% of the visits.
AOE has a relevant social and economic impact. Despite most cases are mild to moderate, AOE can prevent patients from attending school or work.
OTIDRY-MD® is on otic solution that dries the outer ear canal, slightly acidifies the otic environment and soothes the outer ear skin, all of this aimed a preventing otitis externa.
OTIDRY-MD® was launched in 2020 and is now one of our products available in 7 countries.
The formulation is based on a well-known and validated compound formulation widely used by swimmers and other water sports lovers.
Because a dry ear is a healthy ear.
Acute Otitis Externa (AOE) -also known as Swimmer’s Ear”- is a common problem encountered in emergency medicine especially in the summer months. The symptoms are ear discomfort (ranging from pruritus till severe pain), otorrhea (ear discharge) and in case of severe swelling, aural fullness and loss of hearing.
In 2017, 2.4 million U.S. health care visits resulted in a diagnosis of AOE annually which represents 0.8% of the visits.
AOE has a relevant social and economic impact. Despite most cases are mild to moderate, AOE can prevent patients from attending school or work.
OTIDRY-MD® is on otic solution that dries the outer ear canal, slightly acidifies the otic environment and soothes the outer ear skin, all of this aimed a preventing otitis externa.
OTIDRY-MD® was launched in 2020 and is now one of our products available in 7 countries.
The formulation is based on a well-known and validated compound formulation widely used by swimmers and other water sports lovers.
FLASHDENT®
If you’re a pharma business developer, this product will make your mouth water.
The chronic sensation of a dry mouth is a disease condition called xerostomia and affects a large part of the population. Xerostomia is associated with decreased secretion or qualitative changes in saliva proteins and immunoglobulin concentrations that develop because of salivary gland dysfunction. Several reasons causing dry mouth are described, and usually, they include taking medications, local or systemic diseases (like diabetes or Sjögren syndrome) or head and neck radiotherapy.
In addition to the discomfort experienced by the patients and considerable distress, patients with insufficient saliva may also suffer from an increased risk of oral infections, a higher rate of caries (saliva contributes to teeth remineralization), increased dental expenses and decreased quality of life.
FLASHDENT® are refreshing, mouth-watering sugar-free lozenges with lasting effects that stimulate the secretion of saliva, help to alleviate this chronic problem as well as reduce the formation of dental plaque and promote dental remineralisation.
If you’re a pharma business developer, this product will make your mouth water.
The chronic sensation of a dry mouth is a disease condition called xerostomia and affects a large part of the population. Xerostomia is associated with decreased secretion or qualitative changes in saliva proteins and immunoglobulin concentrations that develop because of salivary gland dysfunction. Several reasons causing dry mouth are described, and usually, they include taking medications, local or systemic diseases (like diabetes or Sjögren syndrome) or head and neck radiotherapy.
In addition to the discomfort experienced by the patients and considerable distress, patients with insufficient saliva may also suffer from an increased risk of oral infections, a higher rate of caries (saliva contributes to teeth remineralization), increased dental expenses and decreased quality of life.
FLASHDENT® are refreshing, mouth-watering sugar-free lozenges with lasting effects that stimulate the secretion of saliva, help to alleviate this chronic problem as well as reduce the formation of dental plaque and promote dental remineralisation.
BONRIZE®
Calcium is only one part in the bone health equation.
Bone mass loss can lead to severe bone disease like osteoporosis. Osteoporosis is a silent disease which causes a reduction of bone mass and mechanical resistance, making bones prone to fracture.
All osteoporotic fractures account for more than 2.7 million fractures in men and women in Europe.
Even though calcium plus vitamin D has been the cornerstone treatment for osteoporosis, latest published evidences are challenging the safety of traditional supplementation with calcium in population with increased cardiovascular risk.
BONRIZE® is a breakthrough, patent protected food supplement, formulated as chewable tablet, to address bone wellness and prevent osteoporosis.
One of our products that its main ingredient, phytate, is a potent modulator of bone calcification resorption with a similar mechanism of action to bisphosphonates, but without its side effects.
Phytate has compelling amount of preclinical and clinical evidence showing how it helps to restore balanced calcification.
Quite simply, it’s never been seen before!
Calcium is only one part in the bone health equation.
Bone mass loss can lead to severe bone disease like osteoporosis. Osteoporosis is a silent disease which causes a reduction of bone mass and mechanical resistance, making bones prone to fracture.
All osteoporotic fractures account for more than 2.7 million fractures in men and women in Europe.
Even though calcium plus vitamin D has been the cornerstone treatment for osteoporosis, latest published evidences are challenging the safety of traditional supplementation with calcium in population with increased cardiovascular risk.
BONRIZE® is a breakthrough, patent protected food supplement, formulated as chewable tablet, to address bone wellness and prevent osteoporosis.
One of our products that its main ingredient, phytate, is a potent modulator of bone calcification resorption with a similar mechanism of action to bisphosphonates, but without its side effects.
Phytate has compelling amount of preclinical and clinical evidence showing how it helps to restore balanced calcification.
Quite simply, it’s never been seen before!